A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Inhaled XQ-001 in Healthy Subjects
Clinical trial NCT06918366 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06918366
- Sponsor
- Brilliant Inspiration Biotherapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-03-31
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.